Journal of Asian Natural Products Research · 2019 · 18 citations · 19 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyApoptosis In CancerApoptosis ResistanceCancer ChemopreventionColorectal CancerCytotoxic ChemotherapyMalignant Neoplasms5-Fluorouracil Therapy5-Fluorouracil TreatmentAnticancer ActivityAnticancer ChemotherapyChemotherapy-induced ApoptosisP53 MutationP53-mediated ApoptosisP53-mediated Cell Death
Mutant p53 is primarily responsible for ineffectiveness of many anticancer drugs. The present study showed that cepharanthine alone or combined with 5-fluorouracil effectively controlled the growth of HT-29 human colorectal cancer cells harboring mutant p53 both in vitro and in vivo. The combination of cepharanthine and 5-fluorouracil additively induced apoptotic and necrotic cell death. Their combination significantly upregulated the expression of BAK and cleaved PARP in tumor tissues. Moreover, cepharanthine could prevent 5-fluorouracil-induced BCRP and MRP1 expression. These findings suggest that cepharanthine is a promising agent for treating patients with colorectal cancer containing p53 mutation.
19
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold, Mónica S. Sierra, Mathieu Laversanne et al. · Gut · 2016 · 5.3K citations · Full text